NDC 13537-687-01 - LBEL EFFET PARFAIT signs of age appearance minimizer foundation SPF 20 FM CLAIRE 1 - BEIGE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13537-687
- Requested NDC
- 13537-687-01
- Package NDCs from labels
- 13537-687-01, 13537-687-02
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2016-02-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Octinoxate - Ventura Corporation LTD | Bel Star S.A. (Colombia) | Ventura Corporation LTD | Bel Star S.A. (Colombia) | 2016-02-12 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-687-02 | 2025-03-20 | C162847 | 48780-1 | 9d75b9d0-0727-f424-e053-dadaa90a57ce | LBEL EFFET PARFAIT signs of age appearance minimizer foundation SPF 20 FM |
| 13537-687-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0727-f424-e053-dadaa90a57ce | LBEL EFFET PARFAIT signs of age appearance minimizer foundation SPF 20 FM |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Gas Relief Extra Strength | SIMETHICONE | Target Corporation | 7acc8f43-622a-499f-a374-1079d25b1768 | 2026-11-04 | Warnings | 92RU3N3Y1O |
| Extra Strength Simethicone | SIMETHICONE | Bi-Mart | 9889575e-6ea3-437a-99e9-f6fe8bcecf25 | 2026-11-03 | Warnings | 92RU3N3Y1O |
| EXTRA STRENGTH SIMETHICONE | SIMETHICONE | Bi-Mart | c1b88a30-ffeb-431c-ab73-728cdc786de0 | 2026-11-03 | Warnings | 92RU3N3Y1O |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| Selan Plus Zinc Oxide | SELAN PLUS ZINC OXIDE | Trividia Manufacturing Solutions, Inc | 07396c61-1dfd-4be7-bddf-0eb570a18463 | 2026-11-03 | Warnings | 92RU3N3Y1O |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Shield Line LLC | 5f627926-b8de-c02a-e063-6294a90aa7a5 | 2026-11-03 | Warnings | 4T6H12BN9U |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| SPF 50 Face Sunscreen Bioelements | AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | Cosmetic Enterprises Ltd | 498b16c8-ba54-4a0a-8dbc-4b5cc368e214 | 2026-11-03 | Warnings | 4Y5P7MUD51 |
| Extra Strength Gas Relief | SIMETHICONE ANTIGAS | SAFEWAY | cbbd43eb-1155-4e0d-bed4-32343f34b503 | 2026-11-03 | Warnings | 92RU3N3Y1O |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40f46b-c6b2-df1f-e063-6394a90afd96 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 39N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41120a-521a-f5ac-e063-6394a90ac021 | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.